Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.
Location: United States, California, Menlo Park
Employees: 1-10
Total raised: $5M
Investors 1
| Date | Name | Website |
| - | Lagunita B... | lagunitabi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.08.2018 | Series A | $5M | - |
Mentions in press and media 5
| Date | Title | Description |
| 28.08.2020 | Podcast potpourri | Dr. Rahhal is quickly becoming a prolific podcaster. In this week's roundup Firas hosts three podcasts with another impressive list of guests offering different perspectives on ophthalmic innovation. In this third OIS Retina Podcast, host ... |
| 06.08.2018 | Kedalion Therapeutics Closes $5M Series A | MENLO PARK, CA, Clinical-stage company focused on the development and commercialization of topical ophthalmology therapies has inked a $5 million Series A financing. >> Click here for more funding data on Kedalion Therapeutics >... |
| 06.08.2018 | Kedalion Therapeutics Closes $5 Million Series A Financing Round | MENLO PARK, Calif.–(BUSINESS WIRE)–August 6, 2018– Kedalion Therapeutics, Inc., a clinical-stage company focused on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream™ platform, today... |
| 06.08.2018 | Kedalion raises $5M in Series A round for topical eye drug delivery product | According to medical research and media reports cited by the company, current methods for administering topical eye medications result in too much medicine being administered, most patients dosing improperly, contamination of administration... |
| - | Kedalion raises $5M in Series A round for topical eye drug delivery product | A company developing a system designed to reduce the amount of topical eye medication necessary to achieve therapeutic benefit while improving accuracy plans to advance the technology’s development with proceeds from a financing round that ... |